DIA Biosimilars 2013

Jazz Pharmaceuticals

Jazz, Concert partner to develop deuterium-modified sodium oxybate

Wednesday, February 27, 2013 11:54 AM

Jazz Pharmaceuticals, an Irish specialty biopharmaceutical company focused on unmet medical needs, and Concert Pharmaceuticals, a Lexington, Mass.-based clinical stage biotechnology company, have signed an exclusive license agreement that provides Jazz Pharmaceuticals worldwide rights to develop and commercialize Concert's deuterium-modified sodium oxybate (D-SXB) compounds, including C-10323.   

More... »

Cenduit: Now with Patient Reminders

Longitude Capital closes second life sciences fund with $385M

Friday, October 12, 2012 12:13 PM

Longitude Capital has closed the Longitude Venture Partners II, a $385 million venture capital fund dedicated to investments in drug development and medical technology. 

More... »

CRF Health – eCOA Forum

Jazz Pharmaceuticals to sell women's health business to Meda

Friday, September 7, 2012 10:31 AM

Jazz Pharmaceuticals, a specialty pharmaceutical company based in Dublin, has inked an agreement to sell its women's health business to Meda, an international specialty pharmaceutical company based in Sweden, for $95 million in cash.

More... »

Jazz to acquire EUSA Pharma for $650 million

Friday, April 27, 2012 01:21 PM

Jazz Pharmaceuticals has agreed to acquire EUSA Pharma, a privately-held, specialty pharmaceutical company with headquarters in the U.S. and U.K., for $650 million in cash and a potential $50 million milestone payable in cash based upon its lead product, Erwinaze, achieving a specified U.S. net sales target in 2013.

More... »

Jazz makes management appointments

Monday, January 30, 2012 02:28 PM

Jazz Pharmaceuticals, a biopharmaceutical company specializing in products that address unmet medical needs, has appointed the following individuals to senior management positions:

More... »

Jazz and Azur merge to form Jazz Pharmaceuticals

Friday, January 20, 2012 10:48 AM

Jazz Pharmaceuticals and Azur Pharma have completed their business combination, creating Jazz Pharmaceuticals plc, a specialty biopharmaceutical company based in Dublin, Ireland. 

More... »

Tobias joins Jazz Pharmaceuticals

Wednesday, September 28, 2011 11:16 AM

Jazz Pharmaceuticals has named Jeffrey Tobias, MD, senior vice president of research & development and chief medical officer, effective October 17.

More... »

CenterWatch Drugs in Clinical Trials Database Library. Drug intelligence right at your fingertips.
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

Copyright © 1995-2013 CenterWatch.